In pancreatic carcinoma, both the canonical PAX6 isoform (a) and isoform (b) (also known as 5a) are expressed and promote the expression of MET, which has been linked to pancreatic cancer progression [146,167]. Here, PAX6 is linked to exocrine pancreatic carcinoma.